Bearish
ResMed added as new short idea at Hedgeye
Hedgeye has added ResMed (RMD) as a new short idea, predicting a potential 30% decline in its share price. The rationale behind this forecast is the i...
RMD
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (14)
Neutral (15)
Bearish (1)
Latest RMD News
Bearish
Bullish
ResMed: GLP-1 Threats Are Overstated (NYSE:RMD)
The author believes that concerns about GLP-1 drugs impacting ResMed (RMD) are overblown, arguing that while some market share may be lost, the remain...
Neutral
ResMed chairman & CEO Michael Farrell sells $968k in stock
Michael J. Farrell, Chairman and CEO of ResMed Inc., sold 4,991 shares of the company's common stock for $968,064 on June 8, 2026, after exercising op...
Resmed Insider Sold Shares Worth $968,064, According to a Recent SEC Filing
An insider at ResMed (RMD) recently sold shares valued at $968,064, as disclosed in a filing with the U.S. Securities and Exchange Commission (SEC). T...
Neutral
ResMed (NYSE: RMD) CEO sells 4,991 shares after option exercise
ResMed's Chairman and CEO, Michael J. Farrell, exercised options to acquire 4,991 shares of company stock at $146.34 per share and subsequently sold t...
Neutral
ResMed Inc. $RMD Shares Sold by Marietta Investment Partners LLC
Marietta Investment Partners LLC significantly reduced its stake in ResMed Inc. ($RMD) by 87.7% in the fourth quarter, selling 8,648 shares. This sale...
Bullish
Resmed completes $340M Noctrix takeover
Resmed has completed its $340 million acquisition of Noctrix Health, adding a noninvasive device for restless legs syndrome (RLS) to its product portf...
Bullish
Fideuram Asset Management Ireland dac Acquires New Stake in ResMed Inc. $RMD
Fideuram Asset Management Ireland dac has acquired a new stake in ResMed Inc. (NYSE:RMD) during the fourth quarter, purchasing 18,991 shares valued at...
Neutral
Form 144: RMD (NYSE) affiliate lists 8,000 shares; insider sold 2,000
A Form 144 filing for ResMed Inc. (RMD) reports that 8,000 shares associated with Fidelity Brokerage Services LLC are listed for resale, with an aggre...
Neutral
Jefferies Financial Group Inc. Cuts Stock Holdings in ResMed Inc. $RMD
Jefferies Financial Group Inc. has reduced its stake in ResMed Inc. by 34.4% in the fourth quarter, selling 7,516 shares. Despite this, several other ...
Neutral
Tandem Investment Advisors Inc. Cuts Holdings in ResMed Inc. $RMD
Tandem Investment Advisors Inc. reduced its stake in ResMed Inc. by 1.0% in the fourth quarter, selling 5,071 shares but still holding over 500,000 sh...
Neutral
ResMed Stock Near 52-Week Low Despite 21% EPS Growth: Here’s What the GLP-1 Data Actually Shows
ResMed Inc. reported strong Q3 2026 results, exceeding revenue and EPS estimates with significant year-over-year growth. Despite its stock trading nea...
Neutral
Life Cycle Investment Partners Ltd Invests $31.23 Million in ResMed Inc. $RMD
Life Cycle Investment Partners Ltd recently acquired a new stake in ResMed Inc. (NYSE:RMD), purchasing 129,653 shares valued at approximately $31.23 m...
Bullish
Catalyst Funds Management Pty Ltd Sells 8,400 Shares of ResMed Inc. $RMD
Catalyst Funds Management Pty Ltd reduced its stake in ResMed Inc. by 43.6% in the fourth quarter, selling 8,400 shares and retaining 10,859 shares va...
Bullish
ResMed Inc. (NYSE:RMD) Given Average Rating of "Moderate Buy" by Analysts
ResMed Inc. (NYSE:RMD) has received an average analyst rating of "Moderate Buy" from fifteen brokerages, with an average 12-month price target of $286...
Bullish
Cumberland Partners Ltd Purchases 8,000 Shares of ResMed Inc. $RMD
Cumberland Partners Ltd significantly increased its stake in ResMed Inc. by purchasing an additional 8,000 shares, bringing its total holdings to 21,0...
Bullish
Thrivent Financial for Lutherans Buys 11,481 Shares of ResMed Inc. $RMD
Thrivent Financial for Lutherans significantly increased its stake in ResMed Inc. (NYSE:RMD) during the fourth quarter of 2025, purchasing an addition...
Bullish
ResMed stock (US7611521078): sleep apnea specialist in focus after latest quarterly results
ResMed (US7611521078) remains a key player in the sleep and respiratory care market, combining medical devices, recurring consumables, and cloud-based...
Neutral
5,006 Shares in ResMed Inc. $RMD Acquired by North Dakota State Investment Board
The North Dakota State Investment Board recently acquired 5,006 shares of ResMed Inc. (NYSE:RMD), valued at approximately $1.2 million, during the fou...
Bullish
Resmed, Oura partner on sleep health education, care
Resmed and Oura have announced a partnership to expand access to sleep health education and care, aiming to help individuals better understand and imp...
Research RMD on:
Ad Space